Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto in Peripheral Arterial Disease
NCT02636283Phase 2Terminated
- Sponsor
- University of Minnesota
- Start
- Dec 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in Peripheral Arterial Disease (PAD), sponsored by University of Minnesota. Started Dec 2017; status: terminated.
02
Drugs
sacubitril + valsartan
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02636283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636283.